Loading...

Product review: avelumab, an anti-PD-L1 antibody

Although immunotherapies have been employed for many decades, immune checkpoint inhibitors have only recently entered the oncologic landscape. Avelumab is a fully human monoclonal antibody that blocks the interaction between PD-L1 on tumor cells and PD-1 on T cells, thereby inhibiting immunosuppress...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Hum Vaccin Immunother
Main Authors: Collins, Julie M., Gulley, James L.
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6605872/
https://ncbi.nlm.nih.gov/pubmed/30481100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1551671
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!